These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3659579)

  • 41. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
    Fabre D; Bressolle F; Gomeni R; Arich C; Lemesle F; Beziau H; Galtier M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2521-5. PubMed ID: 1810184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of age on the pharmacokinetics of nimodipine.
    Mück W; Breuel HP; Kuhlmann J
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):293-8. PubMed ID: 8832305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs.
    Nouws JF; Mevius DJ; Vree TB; Baars AM; Laurensen J
    Vet Q; 1988 Jul; 10(3):156-63. PubMed ID: 3176294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of haemodialysis on the pharmacokinetics of ciprofloxacin.
    Samsom JP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S23-5. PubMed ID: 3438149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a Kampo preparation, byakkokaninjinto, on pharmacokinetics of ciprofloxacin and tetracycline.
    Ohnishi M; Hitoshi K; Katoh M; Nadai M; Abe F; Kurono S; Saito H; Haniuda M; Hasegawa T
    Biol Pharm Bull; 2009 Jun; 32(6):1080-4. PubMed ID: 19483319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous ciprofloxacin disposition in obesity.
    Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M
    Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative bioavailability of two brands of ciprofloxacin: an Indian study.
    Suthakaran C; Rajaram S; Adithan C
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):66-8. PubMed ID: 1551749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
    Shah J; Teitelbaum P; Molony B; Gabuzda T; Massey I
    Br J Clin Pharmacol; 1991 Dec; 32(6):761-4. PubMed ID: 1768571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pleural penetration of ciprofloxacin in patients with empyema thoracis.
    Morgenroth A; Pfeuffer HP; Seelmann R; Schweisfurth H
    Chest; 1991 Aug; 100(2):406-9. PubMed ID: 1864115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.
    Nix DE; Watson WA; Handy L; Frost RW; Rescott DL; Goldstein HR
    Pharmacotherapy; 1989; 9(6):377-80. PubMed ID: 2616352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers.
    Polk RE; Healy DP; Sahai J; Drwal L; Racht E
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1841-4. PubMed ID: 2610494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of mianserin.
    Shami M; Elliott HL; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):313S-322S. PubMed ID: 6824562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?
    Tolentino-Hernández SJ; Cruz-Antonio L; Pérez-Urizar J; Cabrera-Fuentes HA; Castañeda-Hernández G
    Arch Med Res; 2020 Apr; 51(3):268-277. PubMed ID: 32143939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers.
    Norbury HM; Franklin RA; Marrott PK; Warrington SJ
    Eur J Clin Pharmacol; 1984; 27(2):247-9. PubMed ID: 6499905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of ciprofloxacin in elderly subjects.
    LeBel M; Barbeau G; Bergeron MG; Roy D; Vallée F
    Pharmacotherapy; 1986; 6(2):87-91. PubMed ID: 2940518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of age on the pharmacokinetics of dipyrone.
    Zylber-Katz E; Granit L; Stessman J; Levy M
    Eur J Clin Pharmacol; 1989; 36(5):513-6. PubMed ID: 2753071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption.
    Ljungberg B; Nilsson-Ehle I; Edlund C; Nord CE
    Scand J Infect Dis; 1990; 22(2):205-8. PubMed ID: 2356443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.